PAGE4 is an X-linked intrinsically disordered protein that functions primarily as a stress-response regulator and transcriptional coactivator in prostate tissue 1. As a coactivator, PAGE4 potentiates the transcriptional activity of the AP-1 complex (particularly c-Jun) through phosphorylation-dependent conformational switching 2. Mechanistically, phosphorylation by homeodomain-interacting protein kinase 1 (HIPK1) at threonine 51 induces a compact conformational ensemble that enhances AP-1 binding, whereas hyperphosphorylation by CDC-like kinase 2 (CLK2) expands PAGE4's structure and attenuates this interaction 32. PAGE4 also protects cells from stress-induced apoptosis by suppressing reactive oxygen species production and regulating MAPK signaling 4. Additionally, PAGE4 acts as a tissue-specific inhibitor of Tankyrase 1, functioning as a substrate decoy to suppress Wnt/β-catenin signaling in prostate fibroblasts 5. Clinically, PAGE4 dysregulation is implicated in prostate cancer progression; PAGE4 attenuates androgen receptor signaling and predicts favorable survival in hormone-naive prostate cancer, suggesting potential as both a prognostic biomarker and therapeutic target 61. The phosphorylation-induced conformational dynamics of PAGE4 may modulate transitions between androgen-dependent and androgen-independent cancer phenotypes 7.